Short Interest in PURE Bioscience, Inc. (OTCMKTS:PURE) Grows By 50.8%

PURE Bioscience, Inc. (OTCMKTS:PURE) was the recipient of a large growth in short interest during the month of October. As of October 31st, there was short interest totalling 46,600 shares, a growth of 50.8% from the October 15th total of 30,900 shares. Based on an average trading volume of 50,300 shares, the days-to-cover ratio is presently 0.9 days.

PURE Bioscience Price Performance

PURE stock remained flat at $0.16 during trading on Friday. 21,473 shares of the company’s stock were exchanged, compared to its average volume of 28,810. The stock has a market cap of $17.62 million, a P/E ratio of -3.94 and a beta of 0.05. PURE Bioscience has a twelve month low of $0.06 and a twelve month high of $0.17. The stock has a 50 day moving average price of $0.09 and a 200 day moving average price of $0.08.

PURE Bioscience (OTCMKTS:PURE) last released its earnings results on Tuesday, October 29th. The company reported ($0.01) earnings per share (EPS) for the quarter. The firm had revenue of $0.47 million during the quarter.

About PURE Bioscience

PURE Bioscience, Inc develops and commercializes antimicrobial products that provide solutions to the health and environmental challenges of pathogen and hygienic control in the United States and internationally. The company manufactures and distributes silver dihydrogen citrate (SDC), a non-toxic antimicrobial agent, which offers residual protection, as well as formulates with other compounds.